Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Stuxnet Facilitates the Degradation of Polycomb Protein during Development.

Du J, Zhang J, He T, Li Y, Su Y, Tie F, Liu M, Harte PJ, Zhu AJ.

Dev Cell. 2016 Jun 20;37(6):507-19. doi: 10.1016/j.devcel.2016.05.013.

2.

Polycomb inhibits histone acetylation by CBP by binding directly to its catalytic domain.

Tie F, Banerjee R, Fu C, Stratton CA, Fang M, Harte PJ.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E744-53. doi: 10.1073/pnas.1515465113. Epub 2016 Jan 22.

3.

Harnessing gene repression to inhibit leukemia.

Harte PJ, Ernst P.

Nat Med. 2015 Apr;21(4):308-10. doi: 10.1038/nm.3834. No abstract available.

PMID:
25849269
4.

Trithorax monomethylates histone H3K4 and interacts directly with CBP to promote H3K27 acetylation and antagonize Polycomb silencing.

Tie F, Banerjee R, Saiakhova AR, Howard B, Monteith KE, Scacheri PC, Cosgrove MS, Harte PJ.

Development. 2014 Mar;141(5):1129-39. doi: 10.1242/dev.102392.

5.

Polycomb silencing of the Drosophila 4E-BP gene regulates imaginal disc cell growth.

Mason-Suares H, Tie F, Yan CM, Harte PJ.

Dev Biol. 2013 Aug 1;380(1):111-24. doi: 10.1016/j.ydbio.2013.03.011. Epub 2013 Mar 20.

6.

Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27.

Tie F, Banerjee R, Conrad PA, Scacheri PC, Harte PJ.

Mol Cell Biol. 2012 Jun;32(12):2323-34. doi: 10.1128/MCB.06392-11. Epub 2012 Apr 9.

7.
8.

Polycomb Repressive Complex 2 and Trithorax modulate Drosophila longevity and stress resistance.

Siebold AP, Banerjee R, Tie F, Kiss DL, Moskowitz J, Harte PJ.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):169-74. doi: 10.1073/pnas.0907739107. Epub 2009 Dec 14.

9.

CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing.

Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC, Harte PJ.

Development. 2009 Sep;136(18):3131-41. doi: 10.1242/dev.037127.

10.

Drosophila ESC-like can substitute for ESC and becomes required for Polycomb silencing if ESC is absent.

Kurzhals RL, Tie F, Stratton CA, Harte PJ.

Dev Biol. 2008 Jan 1;313(1):293-306. Epub 2007 Oct 25.

11.

The N terminus of Drosophila ESC binds directly to histone H3 and is required for E(Z)-dependent trimethylation of H3 lysine 27.

Tie F, Stratton CA, Kurzhals RL, Harte PJ.

Mol Cell Biol. 2007 Mar;27(6):2014-26. Epub 2007 Jan 8.

12.

The N-terminus of Drosophila ESC mediates its phosphorylation and dimerization.

Tie F, Siebold AP, Harte PJ.

Biochem Biophys Res Commun. 2005 Jul 1;332(2):622-32.

PMID:
15896722
13.

SIR2 is required for polycomb silencing and is associated with an E(Z) histone methyltransferase complex.

Furuyama T, Banerjee R, Breen TR, Harte PJ.

Curr Biol. 2004 Oct 26;14(20):1812-21.

14.

A 1-megadalton ESC/E(Z) complex from Drosophila that contains polycomblike and RPD3.

Tie F, Prasad-Sinha J, Birve A, Rasmuson-Lestander A, Harte PJ.

Mol Cell Biol. 2003 May;23(9):3352-62.

15.
16.

A new family of cyclophilins with an RNA recognition motif that interact with members of the trx/MLL protein family in Drosophila and human cells.

Anderson M, Fair K, Amero S, Nelson S, Harte PJ, Diaz MO.

Dev Genes Evol. 2002 Apr;212(3):107-13. Epub 2002 Mar 6.

PMID:
11976948
17.

Interaction between the Drosophila CAF-1 and ASF1 chromatin assembly factors.

Tyler JK, Collins KA, Prasad-Sinha J, Amiott E, Bulger M, Harte PJ, Kobayashi R, Kadonaga JT.

Mol Cell Biol. 2001 Oct;21(19):6574-84.

18.

Localization of endogenous and recombinant Na(+)-driven anion exchanger protein NDAE1 from Drosophila melanogaster.

Sciortino CM, Shrode LD, Fletcher BR, Harte PJ, Romero MF.

Am J Physiol Cell Physiol. 2001 Aug;281(2):C449-63.

19.
20.

Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter.

Romero MF, Henry D, Nelson S, Harte PJ, Dillon AK, Sciortino CM.

J Biol Chem. 2000 Aug 11;275(32):24552-9.

21.

Mouse homolog of the Drosophila Pc-G gene esc exerts a dominant negative effect in Drosophila.

Wang J, Tie F, Jane E, Schumacher A, Harte PJ, Magnuson T.

Genesis. 2000 Jan;26(1):67-76.

PMID:
10660674
22.
23.
24.
25.
27.
29.
31.
32.

Structure and expression of a family of Ultrabithorax mRNAs generated by alternative splicing and polyadenylation in Drosophila.

Kornfeld K, Saint RB, Beachy PA, Harte PJ, Peattie DA, Hogness DS.

Genes Dev. 1989 Feb;3(2):243-58.

33.

Suppurative inflammation of vas deferens: an unusual groin mass.

Ryan SP, Harte PJ.

Urology. 1988 Mar;31(3):245-6.

PMID:
3347975
34.

Regulation and products of the Ubx domain of the bithorax complex.

Hogness DS, Lipshitz HD, Beachy PA, Peattie DA, Saint RB, Goldschmidt-Clermont M, Harte PJ, Gavis ER, Helfand SL.

Cold Spring Harb Symp Quant Biol. 1985;50:181-94. No abstract available.

PMID:
3938361
35.

Acute upper gastro-intestinal haemorrhage in a patient with choledochoduodenal fistula.

Harte PJ, Hyland JM, Browne HJ.

Ir Med J. 1984 Nov;77(11):353-4. No abstract available.

PMID:
6334667
36.

Paratesticular leiomyosarcoma: an ultrastructural study.

Gaffney EF, Harte PJ, Browne HJ.

J Urol. 1984 Jul;132(1):133-4.

PMID:
6726943
37.
38.

Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats.

Rodrick ML, Steele G Jr, Ross DS, Lahey SJ, Deasy JM, Rayner AA, Harte PJ, Wilson RE, Munroe AE, King VP.

J Natl Cancer Inst. 1983 Jun;70(6):1113-8.

PMID:
6602239
39.
40.

Circulating immune complex levels in patients with gestational trophoblastic neoplasia.

Rayner AA, Berkowitz R, Steele G Jr, Schur PH, Rodrick ML, Goldstein DP, Harte PJ, Wilson RE, Zamcheck N, Munroe AE.

J Natl Cancer Inst. 1982 Jul;69(1):23-6.

PMID:
6285061
41.

Duration of anaesthesia and post-operative hypoxaemia.

Harte PJ, Courtney DF, O'Sullivan EG, Brady MP.

Ir J Med Sci. 1982 Jun;151(6):169-74. No abstract available.

PMID:
7107176
42.

The effect of "tissue-type" specific immunotherapy on colon cancer recurrence in a minimal residual disease model.

Harte PJ, Steele G Jr, Rayner AA, Corson JM, Munroe AE, King VP, Wilson RE.

Curr Surg. 1982 Jan-Feb;39(1):21-3. No abstract available.

PMID:
7060396
43.

The effect of adjuvant immunotherapy on tumor recurrence after segmental resection of carcinogen-induced Wistar/Furth primary bowel adenocarcinomas.

Steele G Jr, Harte PJ, Rayner AA, Corson JM, Madara J, Munroe AE, King VP, Wilson RE.

J Immunol. 1982 Jan;128(1):7-10. No abstract available.

PMID:
7054285
44.

Application of polyethylene glycol turbidity assay to detection of circulating immune complexes in cancer patients.

Rayner AA, Steele G Jr, Rodrick ML, Harte PJ, Munroe AE, Zamcheck N, Wilson RE.

Am J Surg. 1981 Apr;141(4):460-4.

PMID:
6784583
45.

Immunogenicity and cross-protection among B16 melanoma variants with differing proclivities to metastasize.

Harte PJ, Steele G Jr, Munroe AE, Rayner AA, Wang BS, Wilson RE, Mannick JA.

J Surg Oncol. 1981;18(4):381-8.

PMID:
7321567
46.

Effect of major small bowel resection on dimethylhydrazine-induced bowel carcinogenesis.

Harte PJ, Steele G Jr, Rayner AA, Munroe AE, King VP, Wilson RE.

J Surg Oncol. 1981;18(1):87-93.

PMID:
7289621
47.

Biliary surgery for benign disease a study of 500 consecutive operations.

Harte PJ, Kirwan WO, Hennessy TP, Gaffney PR, Brady MP.

Ir J Med Sci. 1979 Dec;148(1):297-302. doi: 10.1007/BF02938103.

PMID:
27517441
48.

Biliary surgery for benign disease: a study of 500 consecutive operations.

Harte PJ, Kirwan WO, Hennessy TP, Gaffney PR, Brady MP.

Ir J Med Sci. 1979 Nov-Dec;148(11-12):297-302. No abstract available.

PMID:
541194
49.

Postanaesthetic oxygen.

Parfrey PS, Harte PJ, Quinlan JP, Brady MP.

Br Med J. 1978 Dec 16;2(6153):1713-4. No abstract available.

50.

Postoperative hypoxaemia and oxygen therapy.

Parfrey PS, Harte PJ, Quinlan JP, Brady MP.

Br J Surg. 1977 Jun;64(6):390-3.

PMID:
871610

Supplemental Content

Loading ...
Support Center